Hyperamylasaemia and acute pancreatitis following endoscopic retrograde cholangiopancreatography
- PMID: 2437564
- DOI: 10.1097/00006676-198603000-00009
Hyperamylasaemia and acute pancreatitis following endoscopic retrograde cholangiopancreatography
Abstract
Hyperamylasaemia and acute pancreatitis are the more common complications of endoscopic retrograde cholangiopancreatography (ERCP). Ninety patients who underwent ERCP +/- endoscopic papillotomy were monitored for rises in the serum amylase and the development of acute pancreatitis. The incidence of hyperamylasaemia (greater than 300 IU/L) was significantly greater (p = 0.01) when the pancreatic duct was imaged (75%) than with bile duct imaging alone (33%). The incidence of acute pancreatitis following imaging of the pancreatic duct +/- bile duct was 11.3% and was found to be significantly increased in those patients (n = 9) who also underwent endoscopic papillotomy. Imaging of the biliary tree only +/- endoscopic papillotomy carried no significant risk of acute pancreatitis. In those patients who developed pancreatitis, the rise in serum amylase occurred early and was significantly higher at 2 h following ERCP. These findings may help to identify patients who are at risk of developing this complication.
Similar articles
-
Neutrophil activation and hyperamylasaemia after endoscopic retrograde cholangiopancreatography: potential role for the leukocyte in the pathogenesis of acute pancreatitis.Endoscopy. 2001 May;33(5):448-53. doi: 10.1055/s-2001-14260. Endoscopy. 2001. PMID: 11396766 Clinical Trial.
-
Early treatment of acute biliary pancreatitis by endoscopic papillotomy.N Engl J Med. 1993 Jan 28;328(4):228-32. doi: 10.1056/NEJM199301283280402. N Engl J Med. 1993. PMID: 8418402 Clinical Trial.
-
Post-ERCP pancreatitis and hyperamylasaemia: the role of operative and patient factors.Eur J Gastroenterol Hepatol. 1998 May;10(5):423-8. doi: 10.1097/00042737-199805000-00012. Eur J Gastroenterol Hepatol. 1998. PMID: 9619390
-
Endoscopic approach to acute pancreatitis.Rev Gastroenterol Disord. 2006 Summer;6(3):119-35. Rev Gastroenterol Disord. 2006. PMID: 16957653 Review.
-
Predicting and preventing post-ERCP pancreatitis.Curr Gastroenterol Rep. 2002 Apr;4(2):112-9. doi: 10.1007/s11894-002-0047-6. Curr Gastroenterol Rep. 2002. PMID: 11900675 Review.
Cited by
-
A grey zone of hyperamylasemia following endoscopic retrograde cholangiopancreatography: follow-up and differential diagnosis from acute pancreatitis.Wideochir Inne Tech Maloinwazyjne. 2021 Mar;16(1):38-44. doi: 10.5114/wiitm.2020.94545. Epub 2020 Apr 18. Wideochir Inne Tech Maloinwazyjne. 2021. PMID: 33786115 Free PMC article.
-
Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis.Gut. 1997 Jan;40(1):80-5. doi: 10.1136/gut.40.1.80. Gut. 1997. PMID: 9155580 Free PMC article.
-
Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.Lancet Gastroenterol Hepatol. 2020 Feb;5(2):132-141. doi: 10.1016/S2468-1253(19)30337-1. Epub 2019 Nov 25. Lancet Gastroenterol Hepatol. 2020. PMID: 31780277 Free PMC article. Clinical Trial.
-
Somatostatin and somatostatin analogues--are they indicated in the management of acute pancreatitis?Gut. 1993 Nov;34(11):1622-6. doi: 10.1136/gut.34.11.1622. Gut. 1993. PMID: 7902312 Free PMC article. Review.
-
Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis.Dig Dis Sci. 1998 Aug;43(8):1763-9. doi: 10.1023/a:1018887704337. Dig Dis Sci. 1998. PMID: 9724166
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical